IE49180B1 - Intermediate for use in preparing 17a-acetylene derivatives of androst-4-ene - Google Patents

Intermediate for use in preparing 17a-acetylene derivatives of androst-4-ene

Info

Publication number
IE49180B1
IE49180B1 IE753/85A IE75385A IE49180B1 IE 49180 B1 IE49180 B1 IE 49180B1 IE 753/85 A IE753/85 A IE 753/85A IE 75385 A IE75385 A IE 75385A IE 49180 B1 IE49180 B1 IE 49180B1
Authority
IE
Ireland
Prior art keywords
radical
methyl
compounds
general formula
androst
Prior art date
Application number
IE753/85A
Other versions
IE850753L (en
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7820971A external-priority patent/FR2430952A1/en
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Priority claimed from IE133879A external-priority patent/IE49179B1/en
Publication of IE850753L publication Critical patent/IE850753L/en
Publication of IE49180B1 publication Critical patent/IE49180B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

This invention relates to an intermediate for use in preparing nev/ 17£><-ac.etylene derivatives of androst-^-ene, and tc a process for preparing the intermediate· Ia Paw speuikotim. Me.. 4^^ frcm which thia A^ca-ken is divided there are described and claimed compounds qf the general formula : wherein R~ represents an alkyl radical containing from 2 to 3 caroon atoms; R represents a saturated or unsaturated aliphatic hydrocarbyl radical containing from 1 to 12 carbon atoms, a trifluoromethyl radical, an aryl radical containing from 6 to 12 carbon atoms or an aralkyl radical containing from 7 to 12 carbon atoms; Y represents a hydrogen atom, a fluorine atom or a methyl radical; and the dotted lines in the A and B rings represent optional second carbon-carbon bonds at tho 1(2) and 6(7) positions, with the proviso that when R^ represents a methyl radical 918 0 -2o R represents a saturated or unsaturated aliphatic hydrocarbyl radical and the B ring is saturated, Y represents a methyl radical.
Preferably substituent R^ represents a methyl or ethyl 5 radical, and a particularly preferred group of compounds of the invention comprises those compounds wherein represents a methyl radical.
When R represents a saturated hydrocarbyl radical, this is preferably a methyl, ethyl, n-propyl, isopropyl, ±0 n-butyl, isobutyl. n-pentyl, n-hexyl, 2-methyl-pentyl, 2,3-dimethyl-butyl, n-octyl or 2,2-dinethylhexyl radical, p 'When E represents an unsaturated hydrocarbyl radical, this is preferably a vinyl, isoorocer.yl·, isobutesyli allyl o or 2-methylallyl radical. When represents an aryl radical 2 this is preferably the phenyl radical and when ?. represents an aralkyl radical this is preferably the benzyl radical.
Among the compounds of the Parent invention particularlypreferred groups of compounds of formula I are those wherein the A ring is ethylenic unsaturated at the 1(2) position and those wherein the B.ring is ethylenic unsaturated at the 6(7) position.
Especially preferred compounds of general formula I are those wherein Y represents a hydrogen atom or a methyl radical.
A specific preferred conpound of the Parent invention is most especially 1.1 β , 17[3-dihydraxy-21-methyl--. 17<Χ— - pregna-1,Ί,6-trien-20-yn-3-one.
The Parent invention also provides a process for preparing - 3 the compounds of general formula I, in which a compound either of the general formula: or of the general formula: y (iv) 2 (wherein, in each case R ,R and Y are as defined herein5 before, K represents a blocked ketone function in the form of a ketal or oxime and L represents an alkyl group having from 1 to 12 carbon atoms) is reacted: either with an acid hydrolysis 3gent to obtain a compound -448180 of the general formula: 2 (wherein 5 , ?. and Y are as defined hereinbefore); cr with an agent capable of releasing the ketone function and of creating a Δ 4,6 double bond system to obtain a compound of the general formula: with an agent capable of releasing the ketone function and of creating a Λ 1,^,6 double bond system to obtain a compound of the general formula: 2 wherein R , R. and Y are as defined hereinbefore, When K represents a ketal group this is preferably either a cyclic alkylketal group having from 2 to 4 carbon atcns and especially a ethyleneketal or propyleneketal group, or a dialkylketal such as a dicethylketal or diethylketal group.
When K represents an oxime this is preferably an =;:CK or =K0alk group, alk representing an alkyl radical containing from 1 to a carbon atoms. 1C The alkyl group L preferably represents a methyl, ethyl or n-propyl radical.
The acid hydrolysis agent used in the preparation of compounds L· is preferably a mineral acid such as hydrochloric or sulphuric acid, an organic carboxylic acid such as acetic or citric acid, or a sulphonic acid such as paratoluenesul phonic ncid.
The agent capable of releasing the ketone function and of creating a Δ k,6 system used in the preparation of conpounds lg is preferably a derivative of js-benzoquinone such as 2,3~dicl'.loro-5j6-dicyanobpnzo -6acetone. However, it is also possible, to create a Δ4,6 system by a biochemical route - for example, by using the bacterium ArthrobacteT Simplex.
The agent capable of releasing the ketone function and 5 of creating a Δ 1,4,6 system used in the preparation of compounds Ις is preferably a derivative of p-benzoouinone such as chloranil or 2,3-dichlorc-5,&-dicyarobensoquinone, with the reaction taking place in benzene.
The starting materials of general formula III and IV 10 may conveniently be prepared by rea (V) (VI) Σ ara as defined he re inbefore) as appropriate with a compound of the general formula - 49180 -7TC — CR2 (VII) wherein R is as defined hereinbefore and T represents a lithium or potassium atom or a radical -HalMg, Hal representing a halogen atom.
When substituent T in general formula VII represents a 5 radical -HalMg, the halogen atom is preferahly a bromine atom The compounds of general formulae II, V and VI which are used as starting materials in the processes of the Parent in\rention are, in general, known compounds. They can be prepared, for example, by processes as described in French 1C Patents Nos. 1,359,611 and 1,222,^24 cr in U.S. Patents Nos. 5,010,957 and 5,072,684. -ethoxy-lig-hydroxy-6-methyl-androsta-3,5~dien-17-one, a compound of general formula VI, is however a new compound, and is the subject of· the present inventiony.15 The compounds of general formula I have interesting pharmacological properties, and especially have displayed remarkable anti-inflammatory activity, mainly when applied by topical route.
The compounds of general formula I may be useful in the treatment of polyarthritis, arthrosis and lumbar pains; they are of especial interest for the treatment of local inflammatory reactions such as oedema, dermatoses, pruritis, various forms of eczema and solar erythema.
The following Example illustrates the invention but docs not limit it. . 8 _ Example Preparation of 3-ethoxy-11-hydroxy-6-methyl-androsta-3 ι 5-dicn-17-one. 1.80 g of 1 yj -hydroxy-6pi-methyl-androst-4-ene-3,175 -dione were suspended in a solution containing 10 cm of ethanol and 2 cm of triethoxymethane. The suspension was agitated at 50°C under a current of nitrogen, then 0.25 cm of a solution containing 480 mg of paratoluenesulphonio acid in 50 cm^ of ethanol were added. After 5 o lo minutes 0.4 cmJ of triethylamine were added and the whole was cooled in an ice bath. Water was added drop by drop, and the formed precipitate was vacuum-filtered off, with .ι 7:3 mixture of ethanol and water and dried to obtain 1.66 g of the desired product. Rf = 0.55 (benzene/ethyl acetate , 1:1).
The product prepared as described above can be used to prepare compounds of formula (I) as described in Examples ό and8 of

Claims (3)

1. CLAIMS'
1. 3-Ethoxy-11^3 -hydroxy-6-methyl-androsta-3,5-dien-17-one.
2. A process for the preparation of the compound according to claim 1, which process comprises reacting 11^-hydroxy5 -methyl-androst-A-ene-3,17-dione with triethoxymethane.
3. - A process for the preparation of the compound according to claim 1 substantially as hereinbefore described with reference to tho specific Example. A. The compound according to claim 1 when prepared by a 10 process according to claim 2 or claim 3·
IE753/85A 1978-07-13 1979-08-08 Intermediate for use in preparing 17a-acetylene derivatives of androst-4-ene IE49180B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR7820971A FR2430952A1 (en) 1978-07-13 1978-07-13 NOVEL ACETYLENIC DERIVATIVES OF ANDROST 4-ENE, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS A MEDICAMENT
GB7924588A GB2025422B (en) 1978-07-13 1979-07-13 17-acetylene derivatives of androst-4-ene
IE133879A IE49179B1 (en) 1978-07-13 1979-08-08 17a-acetylene derivatives of androst-4-ene

Publications (2)

Publication Number Publication Date
IE850753L IE850753L (en) 1980-01-13
IE49180B1 true IE49180B1 (en) 1985-08-21

Family

ID=27250840

Family Applications (1)

Application Number Title Priority Date Filing Date
IE753/85A IE49180B1 (en) 1978-07-13 1979-08-08 Intermediate for use in preparing 17a-acetylene derivatives of androst-4-ene

Country Status (1)

Country Link
IE (1) IE49180B1 (en)

Also Published As

Publication number Publication date
IE850753L (en) 1980-01-13

Similar Documents

Publication Publication Date Title
Overberger et al. A convenient synthesis of phenyldiazomethane
SE453089B (en) IMIDAZO RIFAMYCINE DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL COMPOSITION
Schubert The Interaction of Thiols and Quinones1
Dauben et al. A Study of the Mechanism of Conversion of Acetate to Cholesterol via Squalene1
Scheurer et al. Synthesis of acetobromo sugars
HU177333B (en) Process for producing gona-4,9-bracket-10-bracket closeddienes
GB2108503A (en) 3-ethoxy-11b-hydroxy-6-methyl-androsta-3,5-dien-17-one
IE49180B1 (en) Intermediate for use in preparing 17a-acetylene derivatives of androst-4-ene
US4342702A (en) Metallated halogenated acetylene corticoid synthesis
GB2152058A (en) 17-ethynyl-6-fluoro steroids, their preparation and use
US4102907A (en) Desulfinylation process for preparing androsta-4,9(11)-diene-3,17-dione
US2813883A (en) 9alpha-halo-17beta-hydroxy-17alpha-methyl-androstane-3, 11-diones
US3970676A (en) Novel process and intermediate compounds used is preparation of -Δ5,7- steroid dienes
JPS63280094A (en) 3-methylene-4-androstene-17-one, manufacture, estrogen biosynthesis inhibition and impregnation-changeable medicine
KR870001937B1 (en) Process for preparing(3-keto omega 4 or omega 1,4)-7-substituted steroid derivatives
FR2479235A1 (en) 17- (THIO SUBSTITUTED) ANDROST-4-ENE (16,17-B) - (1,4) BENZODIOXIN-3-ONES WITH ANTI-INFLAMMATORY ACTION
Tatsugi et al. A convenient one-pot synthesis of acenaphthenequinones from 1-acenaphthenones by NBS-DMSO oxidation.
HU180520B (en) Process for producing 17-alpha-alkinyl derivatives of 17-beta-hydroxy-andorst-4-ene-3-one
Koppel et al. Synthesis of Some 8-Substituted Bis (β-chloroethyl) amino Derivatives of Naturally Occurring N-Methylated Purines1
US4434080A (en) Dehydrogenation agents based on derivatives of selenium and their use in the dehydrogenation in the 1,4 positions of steroids
HU182775B (en) Process for preparing new 3-chloro-pregnane derivatives
GB2091266A (en) 16,17-pyrazolino-and 16,17-isopyrazolino-1,4-pregnadiene derivatives
US3914318A (en) Process for preparing 4-methylsulfinylbenzaldehyde
US4059611A (en) Oxidative process for the preparation of 2-(5H-dibenzo[a,d]cyclohepten-5-on-2-yl)acetic, propionic and butyric acid
US3136758A (en) Delta16-20-keto-pregnene derivatives and their preparation

Legal Events

Date Code Title Description
MK9A Patent expired